As a healthcare professional transporting patients to the ED, you may serve patients with symptoms indicative of behavioral health disorders, such as depressive, bipolar, and anxiety disorders. In some situations, the ED provider must administer psychiatric medications. However, if possible, it is prudent to defer their use until the patient is admitted to an inpatient mental health facility or seen as an outpatient. In many instances, the reason for presentation in the ED is an adverse reaction to psychiatric medications.
As a healthcare professional transporting patients to the ED, you may serve patients with symptoms indicative of behavioral health disorders, such as depressive, bipolar, and anxiety disorders. In some situations, the ED provider must administer psychiatric medications. However, if possible, it is prudent to defer their use until the patient is admitted to an inpatient mental health facility or seen as an outpatient. In many instances, the reason for presentation in the ED is an adverse reaction to psychiatric medications.
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
District of Columbia Board of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Florida Board of Nursing (CEBroker Provider #50-290)
Georgia Board of Nursing (CEBroker Provider #50-290)
South Carolina Board of Nursing (CEBroker Provider #50-290)
West Virginia Board of Registered Nursing (CEBroker Provider #50-290)
New Mexico Board of Nursing (CEBroker Provider #50-290)
Arkansas State Board Of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Kentucky Board of Nursing (CEBroker Provider #50-290)
Mississippi Board of Nursing (CEBroker Provider #50-290)
North Dakota Board of Nursing (CEBroker Provider #50-290)
Florida Board of Medicine (CEBroker Provider #50-290)
State Medical Board of Ohio (CEBroker Provider #: 50-290)
Louisiana State Board of Medical Examiners (CEBroker Provider #: 50-290)
Mississippi State Board of Medical Licensure (CEBroker Provider #: 50-290)
Physicians will receive 1.25 AMA PRA category 1 Credits™.
South Carolina Board of Medical Examiners (CEBroker Provider #50-290)
Tennessee Board of Medical Examiners (CEBroker Provider #50-290)>
Physicians will receive 1.25 AMA PRA category 1 Credits™
Florida Physician Assistants (CEBroker Provider #50-290)
Outline:
Section 1: Introduction
About This Course
Learning Objectives
Section 2: Psychiatric Medications
Jacob
How Psychiatric Medications Work
Food and Drug Administration (FDA) Approval and Off-Label Use
Summary
Section 3: Antipsychotic Medications
Symptoms of Psychotic Disorders
Antipsychotic Medications
FGAs
Common FGA Adverse Side Effects
SGAs
Treating Acute Psychosis with Antipsychotic Medication
Review
Summary
Section 4: Mood Stabilizer Medications
Bipolar Disorder
Bipolar I and Bipolar II
The Depressive Pole
Bipolar Symptoms in the ED
Lithium
Valproate (Depakote®) for Bipolar Disorder
Other Anticonvulsants for Treating Bipolar Disorder
Antipsychotic Drug Mood Stabilizers
Summary
Section 5: Antidepressant Medications
Signs of Depression
Antidepressants
Other Antidepressants
Common Side Effects of Antidepressants
Serotonin Syndrome
MAOI Hypertensive Crisis
Summary
Section 6: Antianxiety Medications
Anxiety
Antidepressants for Anxiety and Related Disorders
Review
Benzodiazepines
Other Medications for Anxiety
Summary
Section 7: Stimulants and Nonstimulants
Attention Deficit Hyperactivity Disorder
Treatment of ADHD
Stimulants
Non-Stimulants
Summary
Section 8: Medication Use in Special Populations
Special Populations
Summary
Section 9: Conclusion
Course Summary
Course Contributor(s)
References
Johnny received a B.S. Pharmacy degree from the College of Pharmacy at the Medical University of South Carolina. He has earned certificates in Medication Therapy Management, Injectable Medications, and Asthma Therapy Management. At Relias, Johnny serves as a Partner in Behavioral Health Solutions, where duties include serving on Clinical Analytics and Applications Team, developing algorithms to improve clinical outcomes, engineering clinical consultant, SME, writer, and editor. In addition, he has served on the Executive Board of Directors for CMHCs and other medical organizations, pharmacy manager, APPE Preceptor, and college of pharmacy dean’s advisory council. Disclosure: Johnny J. Bethea, II, RPh discloses the following potential conflict of interests/commercial interests: Relevant Financial Relationship with Relias LLC as a Salaried Employee All of the relationships listed for this individual have been mitigated.Relevant Non-Financial Relationship with No Entities Exists as a Contributor All of the relationships listed for this individual have been mitigated.Writer: Zeliha Ozen, MSN, RN, CCRN, CNL
Zeliha has extensive experience in critical care nursing in acute care hospitals, including cardiac intensive care (CICU) and medical intensive care units (MICU). She has served in various roles, including educator, preceptor, charge nurse, and advanced critical care life support (ACLS) instructor. She has extensive experience as a code nurse for a 900-bed hospital. Zeliha has been a lung transplant coordinator for around five years and was responsible for pre-transplant care, waitlist management, and post-lung transplant care. Zeliha has worked on cutting-edge transplant organ procurement initiatives such as Ex-Vivo Lung Perfusion (EVLP) and has managed patients in a hospital that performs around 100 transplants annually. Additionally, Zeliha has served as quality chair council for the heart and vascular services and has worked on several quality initiatives for the service line, such as infection control, cardiac education, nursing resiliency, and nursing onboarding. She has served on various leadership councils in the CICU. She earned a Bachelor of Science in Nursing from Saint John University in Rochester, New York. She has a Master of Science in Nursing and a Master’s in Clinical Nurse Leadership (CNL) from Queens University in Charlotte, North Carolina. She is also certified as a Critical Care Nurse (CCRN).
Disclosure: Zeliha Ozen, MSN, RN, CCRN, CNL has no Relevant Financial or Non-Financial Relationship with ineligible companies to disclose.
Access to over 1,450 courses! Access to 1,450+ courses for one low price.